Juice- both a Saturday morning staple and an adjunct to that near toxic tequila you got for your 18th. Fruity beverage mogul Food Revolution Group (ASX: FOD) is helping keep those crappy tequila brands in the green with the expansion of their range of juices. The Company plans to expand three products throughout the Coles
Read More
Already Australia’s largest and fastest growing allied health portfolio, healthcare operator Healthia (ASX: HLA) has further strengthened its position in the physiotherapy market with the acquisition of Rothwell Physiotherapy in Brisbane. The addition continues a string of acquisitions which included four clinics last month as part of Healthia’s commitment to deploy $20 million towards acquisitions
Read More
Accelerated by the tree-change seeking Victorians that have shifted away from metropolitan Melbourne, massive infrastructure upgrades are underway across regional Victoria with construction company Decmil (ASX: DCG) securing their second big contract within a few months. The contract awarded by Major Road Projects Victoria (MRPV) is valued at $88.7 million to Decmil which will immediately
Read More
With consumers becoming increasingly environmentally conscious, sustainable packaging is becoming the new norm. Agricultural waste fibre technology company Papyrus Australia (ASX: PPY) has developed a zero-waste, chemical-free process of converting globally available agri-waste into usable products, thereby reducing the creation of methane and waste. Where do they source this agri-waste? Bananas! On average, one hectare
Read More
Everything is bigger in Texas. And that includes the population of 29 million which alone is larger than all of Australia, opening up a lucrative expansion opportunity to Aussie sports betting company PointsBet (ASX: PBH) which has been appointed the Exclusive Sportsbook Partner of Major League Soccer team Austin FC. The appointment will give PointsBet
Read More
It’s no secret that medical research and development is an expensive pursuit. Many medtech and pharmaceutical companies are constantly on the lookout for non dilutive funding to accelerate their projects, hopefully to market. Medtech company EMVision (ASX: EMV) is focused on developing their portable medical imaging technology. The Company has secured access to $8 million
Read More
